25CN-NBOMe

From The Lycaeum
Jump to: navigation, search
</th></tr>
25CN-NBOMe
200px
Systematic (IUPAC) name
2,5-Dimethoxy-4-(2-(2-methoxybenzylamino)ethyl)benzonitrile
Clinical data
Legal status ?
Identifiers
CAS number 1354632-16-8
ATC code ?
Chemical data
Formula C19H22N2O3 
Mol. mass 326.39 g/mol

25CN-NBOMe (2C-CN-NBOMe, NBOMe-2C-CN) is a derivative of the phenethylamine 2C-CN. It acts in a similar manner to related compounds such as 25I-NBOMe, which are potent agonists at the 5HT2A receptor.[1][2] 25CN-NBOMe has been sold as a street drug since 2010 and produces similar effects in humans to related compounds such as 25I-NBOMe and 25C-NBOMe.

See also

References

  1. Hansen, M.; Phonekeo, K.; Paine, J. S.; Leth-Petersen, S.; Begtrup, M.; Bräuner-Osborne, H.; Kristensen, J. L. (2014). "Synthesis and Structure-Activity Relationships of N-Benzyl Phenethylamines as 5-HT2A/2C Agonists". ACS Chemical Neuroscience: 140107104401000. doi:10.1021/cn400216u.  edit
  2. Hansen, M. Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain. PhD Thesis, University of Copenhagen, 2011.


      
Personal tools
Namespaces

Variants
Actions
Navigation
Forums
Lycaeum IRC Chat
TheAntiDrug Diaspora
Starting Points
Tools